Revance discontinues development of RT-001 for lateral canthal lines on basis of phase III results June 14, 2016
Phase III study of dupilumab in moderate to severe atopic dermatitis meets key endpoints June 6, 2016
Dermira reports topline results from pivotal trials of DRM-04 for primary axillary hyperhidrosis June 3, 2016
RSS